Chancy, Switzerland

Doriane Theurillat

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Arisgen Sa. Active years: 2014.



 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Doriane Theurillat: Innovator in Pharmaceutical Carriers

Introduction

Doriane Theurillat is a notable inventor based in Switzerland. He has made significant contributions to the field of pharmaceutical and diagnostic compositions. His innovative work focuses on the development of carriers that enhance the efficacy of various medical applications.

Latest Patents

Doriane Theurillat holds a patent titled "Orthoester Derivatives Of Crown Ethers As Carriers For Pharmaceutical And Diagnostic Compositions." This invention relates to a crown ether of formula (I) wherein m is 4, 5, 6, 7, or 8 and i is, independently for each occurrence, 1 or 2. The invention specifies that at least one occurrence in the crown ether of R1, R2, and the carbon to which R1 and R2 are attached, said carbon being bound directly to an ether oxygen of formula (I), forms together a group of formula (II) wherein L is a linker which is absent or selected from a covalent bond and (CR5R6)n. This innovative approach is useful as carriers for pharmaceutical and diagnostic compositions.

Career Highlights

Throughout his career, Doriane has worked with prominent companies such as Capsugel Belgium and Paolo Botti. His experience in these organizations has allowed him to refine his expertise in the development of pharmaceutical technologies.

Collaborations

Doriane has collaborated with notable individuals in his field, including Paolo Botti and Sylvie Tchertchian, who is a distinguished woman in the industry.

Conclusion

Doriane Theurillat's contributions to the field of pharmaceutical carriers demonstrate his innovative spirit and commitment to advancing medical technology. His work continues to influence the development of effective diagnostic and therapeutic solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…